150 related articles for article (PubMed ID: 535127)
1. Phase-II trial of tamoxifen in advanced breat cancer.
Wiggans RG; Woolley PV; Smythe T; Hoth D; Macdonald JS; Green L; Schein PS
Cancer Chemother Pharmacol; 1979; 3(1):45-8. PubMed ID: 535127
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of tamoxifen: report of 74 patients with stage IV breast cancer.
Lerner HJ; Band PR; Israel L; Leung BS
Cancer Treat Rep; 1976 Oct; 60(10):1431-5. PubMed ID: 798626
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parameters.
Morgan LR; Schein PS; Woolley PV; Hoth D; Macdonald J; Lippman M; Posey LE; Beazley RW
Cancer Treat Rep; 1976 Oct; 60(10):1437-43. PubMed ID: 191185
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate and 5-fluorouracil following tamoxifen and premarin in advanced breast cancer.
Allegra JC
Semin Oncol; 1983 Jun; 10(2 Suppl 2):23-8. PubMed ID: 6306835
[TBL] [Abstract][Full Text] [Related]
5. Use of tamoxifen in advanced male breast cancer.
Patterson JS; Battersby LA; Bach BK
Cancer Treat Rep; 1980; 64(6-7):801-4. PubMed ID: 7427964
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen (antiestrogen) therapy in advanced breast cancer.
Kiang DT; Kennedy BJ
Ann Intern Med; 1977 Dec; 87(6):687-90. PubMed ID: 931204
[TBL] [Abstract][Full Text] [Related]
7. A phase II study Nolvadex: tamoxifen citrate in the treatment of advanced prostatic adenocarcinoma.
Spremulli E; DeSimone P; Durant J
Am J Clin Oncol; 1982 Apr; 5(2):149-53. PubMed ID: 7091040
[TBL] [Abstract][Full Text] [Related]
8. Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy.
Hoff PM; Valero V; Buzdar AU; Singletary SE; Theriault RL; Booser D; Asmar L; Frye D; McNeese MD; Hortobagyi GN
Cancer; 2000 May; 88(9):2054-60. PubMed ID: 10813717
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study.
Ravdin PM; Green S; Dorr TM; McGuire WL; Fabian C; Pugh RP; Carter RD; Rivkin SE; Borst JR; Belt RJ
J Clin Oncol; 1992 Aug; 10(8):1284-91. PubMed ID: 1634918
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial of estrogen vs. tamoxifen therapy for advanced breast cancer.
Matelski H; Greene R; Huberman M; Lokich J; Zipoli T
Am J Clin Oncol; 1985 Apr; 8(2):128-33. PubMed ID: 3914839
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in elderly women with metastatic breast cancer treated with tamoxifen: an analysis of patients entered on four prospective clinical trials.
Dhodapkar MV; Ingle JN; Cha SS; Mailliard JA; Wieand HS
Cancer; 1996 Feb; 77(4):683-90. PubMed ID: 8616760
[TBL] [Abstract][Full Text] [Related]
12. Clinical experiences with tamoxifen for estrogen receptor blocking therapy in metastatic breast cancer.
Henningsen B
Prog Clin Biol Res; 1977; 12():479-82. PubMed ID: 918118
[No Abstract] [Full Text] [Related]
13. Randomized comparison of tamoxifen versus diethylstilbestrol in estrogen receptor-positive or -unknown metastatic breast cancer: a Southeastern Cancer Study Group trial.
Gockerman JP; Spremulli EN; Raney M; Logan T
Cancer Treat Rep; 1986 Oct; 70(10):1199-203. PubMed ID: 3530447
[TBL] [Abstract][Full Text] [Related]
14. The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer.
Fowble B; Fein DA; Hanlon AL; Eisenberg BL; Hoffman JP; Sigurdson ER; Daly MB; Goldstein LJ
Int J Radiat Oncol Biol Phys; 1996 Jul; 35(4):669-77. PubMed ID: 8690632
[TBL] [Abstract][Full Text] [Related]
15. Oestrogen receptors and the response of metastatic breast cancer to aminoglutethimide or tamoxifen.
Holdaway IM
Aust N Z J Surg; 1981 Aug; 51(4):345-7. PubMed ID: 6944051
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen.
Goss PE; Clark RM; Ambus U; Weizel HA; Wadden NA; Crump M; Walde D; Tye LM; De Coster R; Bruynseels J
Clin Cancer Res; 1995 Mar; 1(3):287-94. PubMed ID: 9815984
[TBL] [Abstract][Full Text] [Related]
17. Phase II trials with toremifene in advanced breast cancer: a review.
Valavaara R
Breast Cancer Res Treat; 1990 Aug; 16 Suppl():S31-5. PubMed ID: 2149283
[TBL] [Abstract][Full Text] [Related]
18. Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association.
Muss HB; Wells HB; Paschold EH; Black WR; Cooper MR; Capizzi RL; Christian R; Cruz JM; Jackson DV; Powell BL
J Clin Oncol; 1988 Jul; 6(7):1098-106. PubMed ID: 3292710
[TBL] [Abstract][Full Text] [Related]
19. Antiestrogens--tamoxifen, SERMs and beyond.
Dhingra K
Invest New Drugs; 1999; 17(3):285-311. PubMed ID: 10665480
[TBL] [Abstract][Full Text] [Related]
20. Endocrine manipulation in advanced breast cancer: recent advances with SERM therapies.
Johnston SR
Clin Cancer Res; 2001 Dec; 7(12 Suppl):4376s-4387s; discussion 4411s-4412s. PubMed ID: 11916228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]